XML 58 R41.htm IDEA: XBRL DOCUMENT v3.26.1

STOCKHOLDERS’ EQUITY (Tables)

12 Months Ended

Dec. 31, 2025

Equity [Abstract]

Schedule of assumptions

Schedule of assumptions
Company stock price on valuation date		$	10.00
Volatility			143.85%
Risk free interest rate - 5 years			3.94%
Risk free interest rate - 10 years			4.43%
Dividend yield			0.00%

Schedule of fair values and derived service periods

Schedule of fair values and derived service periods
		Daily VWAP $10				Daily VWAP $15				Daily VWAP $20				Daily VWAP $25				Daily VWAP $30
Fair value - 5 year service period		$	9.03			$	9.02			$	9.02			$	9.02			$	9.01
Derived service period - years			N/A				0.20				0.38				0.56				0.69
Fair value - 10 year service period		$	9.82			$	9.80			$	9.80			$	9.80			$	9.80
Derived service period - years			N/A				0.20				0.40				0.58				0.73

Schedule of pre-funded common stock warrants

Schedule of pre-funded common stock warrants
		Pre- Funded Common Stock Warrants
		Shares				Weighted Average Exercise Price				Weighted Average Remaining Life in years(1)				Intrinsic Value
Outstanding at January 1, 2025			10,263			$	0.00064
Purchased			6,429,237			$	0.00002
Exercised			(2,525,962	)		$	0.00002
Outstanding at December 31, 2025			3,913,538			$	0.00002				–			$	17,865,238
Exercisable at December 31, 2025			3,913,538			$	0.00002				–			$	17,865,238

(1) Pre-funded warrants expire only upon exercise

Schedule of warrants activity

Schedule of warrants activity
		Other Common Stock Warrants
		Shares				Weighted Average Exercise Price				Weighted Average Remaining Life in years				Intrinsic Value
Outstanding at January 1, 2025			14,804			$	4,158.33
Granted/purchased			1,844,148			$	12.42
Exercised			(123,603	)		$	14.43
Outstanding at December 31, 2025			1,735,349			$	47.66				6.98			$	–
Exercisable at December 31, 2025			1,735,349			$	47.66				6.98			$	–

X

- References

No definition available.

+ Details

Name:	EMPD_ScheduleOfPrefundedCommonStockWarrantsActivityTableTextBlock
Namespace Prefix:	EMPD_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_EquityAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-3

Reference 3: http://www.xbrl.org/2003/role/exampleRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 55
-Paragraph 101
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482078/820-10-55-101

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 820
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482106/820-10-50-2

+ Details

Name:	us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (j)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 715
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480506/715-20-50-1

+ Details

Name:	us-gaap_ScheduleOfAssumptionsUsedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration